Peganum harmala enhanced GLP-1 and restored insulin signaling to alleviate AlCl3-induced Alzheimer-like pathology model
Abstract Peganum harmala (P. harmala) is a folk medicinal herb used in the Sinai Peninsula (Egypt) as a remedy for central disorders. The main constituents, harmine and harmaline, have displayed therapeutic efficacy against Alzheimer’s disease (AD); however, the P. harmala potential on sensitizing c...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ce8e95ce378442d5a027106fd6e53cd9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ce8e95ce378442d5a027106fd6e53cd9 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ce8e95ce378442d5a027106fd6e53cd92021-12-02T17:34:40ZPeganum harmala enhanced GLP-1 and restored insulin signaling to alleviate AlCl3-induced Alzheimer-like pathology model10.1038/s41598-021-90545-42045-2322https://doaj.org/article/ce8e95ce378442d5a027106fd6e53cd92021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-90545-4https://doaj.org/toc/2045-2322Abstract Peganum harmala (P. harmala) is a folk medicinal herb used in the Sinai Peninsula (Egypt) as a remedy for central disorders. The main constituents, harmine and harmaline, have displayed therapeutic efficacy against Alzheimer’s disease (AD); however, the P. harmala potential on sensitizing central insulin to combat AD remains to be clarified. An AD-like rat model was induced by aluminum chloride (AlCl3; 50 mg/kg/day for six consecutive weeks; i.p), whereas a methanolic standardized P. harmala seed extract (187.5 mg/kg; p.o) was given to AD rats starting 2 weeks post AlCl3 exposure. Two additional groups of rats were administered either the vehicle to serve as the normal control or the vehicle + P. harmala seed extract to serve as the P. harmala control group. P. harmala enhanced cognition appraised by Y-maze and Morris water maze tests and improved histopathological structures altered by AlCl3. Additionally, it heightened the hippocampal contents of glucagon-like peptide (GLP)-1 and insulin, but abated insulin receptor substrate-1 phosphorylation at serine 307 (pS307-IRS-1). Besides, P. harmala increased phosphorylated Akt at serine 473 (pS473-Akt) and glucose transporter type (GLUT)4. The extract also curtailed the hippocampal content of beta amyloid (Aβ)42, glycogen synthase (GSK)-3β and phosphorylated tau. It also enhanced Nrf2, while reduced lipid peroxides and replenished glutathione. In conclusion, combating insulin resistance by P. harmala is a novel machinery in attenuating the insidious progression of AD by enhancing both insulin and GLP-1 trajectories in the hippocampus favoring GLUT4 production.Rofida A. SalehTarek F. EissaDalaal M. AbdallahMuhammed A. SaadHanan S. El-AbharNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Rofida A. Saleh Tarek F. Eissa Dalaal M. Abdallah Muhammed A. Saad Hanan S. El-Abhar Peganum harmala enhanced GLP-1 and restored insulin signaling to alleviate AlCl3-induced Alzheimer-like pathology model |
description |
Abstract Peganum harmala (P. harmala) is a folk medicinal herb used in the Sinai Peninsula (Egypt) as a remedy for central disorders. The main constituents, harmine and harmaline, have displayed therapeutic efficacy against Alzheimer’s disease (AD); however, the P. harmala potential on sensitizing central insulin to combat AD remains to be clarified. An AD-like rat model was induced by aluminum chloride (AlCl3; 50 mg/kg/day for six consecutive weeks; i.p), whereas a methanolic standardized P. harmala seed extract (187.5 mg/kg; p.o) was given to AD rats starting 2 weeks post AlCl3 exposure. Two additional groups of rats were administered either the vehicle to serve as the normal control or the vehicle + P. harmala seed extract to serve as the P. harmala control group. P. harmala enhanced cognition appraised by Y-maze and Morris water maze tests and improved histopathological structures altered by AlCl3. Additionally, it heightened the hippocampal contents of glucagon-like peptide (GLP)-1 and insulin, but abated insulin receptor substrate-1 phosphorylation at serine 307 (pS307-IRS-1). Besides, P. harmala increased phosphorylated Akt at serine 473 (pS473-Akt) and glucose transporter type (GLUT)4. The extract also curtailed the hippocampal content of beta amyloid (Aβ)42, glycogen synthase (GSK)-3β and phosphorylated tau. It also enhanced Nrf2, while reduced lipid peroxides and replenished glutathione. In conclusion, combating insulin resistance by P. harmala is a novel machinery in attenuating the insidious progression of AD by enhancing both insulin and GLP-1 trajectories in the hippocampus favoring GLUT4 production. |
format |
article |
author |
Rofida A. Saleh Tarek F. Eissa Dalaal M. Abdallah Muhammed A. Saad Hanan S. El-Abhar |
author_facet |
Rofida A. Saleh Tarek F. Eissa Dalaal M. Abdallah Muhammed A. Saad Hanan S. El-Abhar |
author_sort |
Rofida A. Saleh |
title |
Peganum harmala enhanced GLP-1 and restored insulin signaling to alleviate AlCl3-induced Alzheimer-like pathology model |
title_short |
Peganum harmala enhanced GLP-1 and restored insulin signaling to alleviate AlCl3-induced Alzheimer-like pathology model |
title_full |
Peganum harmala enhanced GLP-1 and restored insulin signaling to alleviate AlCl3-induced Alzheimer-like pathology model |
title_fullStr |
Peganum harmala enhanced GLP-1 and restored insulin signaling to alleviate AlCl3-induced Alzheimer-like pathology model |
title_full_unstemmed |
Peganum harmala enhanced GLP-1 and restored insulin signaling to alleviate AlCl3-induced Alzheimer-like pathology model |
title_sort |
peganum harmala enhanced glp-1 and restored insulin signaling to alleviate alcl3-induced alzheimer-like pathology model |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/ce8e95ce378442d5a027106fd6e53cd9 |
work_keys_str_mv |
AT rofidaasaleh peganumharmalaenhancedglp1andrestoredinsulinsignalingtoalleviatealcl3inducedalzheimerlikepathologymodel AT tarekfeissa peganumharmalaenhancedglp1andrestoredinsulinsignalingtoalleviatealcl3inducedalzheimerlikepathologymodel AT dalaalmabdallah peganumharmalaenhancedglp1andrestoredinsulinsignalingtoalleviatealcl3inducedalzheimerlikepathologymodel AT muhammedasaad peganumharmalaenhancedglp1andrestoredinsulinsignalingtoalleviatealcl3inducedalzheimerlikepathologymodel AT hananselabhar peganumharmalaenhancedglp1andrestoredinsulinsignalingtoalleviatealcl3inducedalzheimerlikepathologymodel |
_version_ |
1718379966576459776 |